QualityStocksNewsBreaks Archives - Page 737 of 1421

TuesdayMar 16, 2021 12:01 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Oppenheimer Health Care Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Oppenheimer 31st Annual Healthcare Conference. Drysdale’s presentation is scheduled to begin at 11:20 a.m. Eastern Time on Thursday, March 18, 2021. Interested parties should visit https://ibn.fm/ZE9G5 to register for the event. The presentation will be webcast live at the aforementioned time and available for seven days thereafter via the above link. To view the full press release, visit https://ibn.fm/6i8Iw About Cybin Inc. Cybin is a leading biotechnology company…

TuesdayMar 16, 2021 11:12 am

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Announces Balance Sheet Update, Physical Uranium Initiative

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, today announced, in accordance with NYSE American requirements, the filing of its quarterly report on Form 10-Q for the six months ended January 31, 2021 with the U.S. Securities and Exchange Commission (the "SEC"). The Form 10-Q filing, which includes UEC’s condensed consolidated financial statements, related notes and management's discussion and analysis, is available for viewing on the SEC's website or the company’s website. "With $65.8 million in cash and equity holdings, UEC has the balance sheet strength to lead U.S. uranium production higher at the…

TuesdayMar 16, 2021 10:47 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results

Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec. 31, 2020, after market close on March 29, 2021. As part of the reporting strategy, MEDS management will host a conference call. The call is scheduled for 5 p.m. ET on Monday, March 29, 2021. During the scheduled event, Trxade Group execs will discuss the…

TuesdayMar 16, 2021 10:22 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Releases AGMS Results, Names New CEO

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) held an annual general and special meeting on Monday, March 15, 2021. The company has announced that all matters outlined in the notice of meeting and information circular, which was sent to all shareholders, were approved and passed. Included in those items was the approval and ratification of MOTNF’s amended and restated investment policy; the policy will now include the renewable energy sector as an area of investment focus for the company. Shareholders also elected and established and named a four-member board of directors. Board members will be Johannes (Theo) van…

TuesdayMar 16, 2021 9:44 am

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Releases FY 2020 Financial Results, Business Highlights

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has reported business highlights and financial results for the year ended Dec. 31, 2020. Highlights discussed in the report include the company’s reinforced balance sheet with net debt and equity offerings for estimated net proceeds of $12,952,689; completion of an asset purchase agreement to acquire Soluble Therapeutics and its exclusive technology, as well as BioDtech Inc.; completion of the asset purchase of Quantitative Medicine (“QM”); and the signing of a contract with a pharmaceutical company for protein expression and solubility studies.…

TuesdayMar 16, 2021 9:21 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Participation in 33rd Annual ROTH Conference

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(r), A88 Infused(TM), and A88CBD(TM), will be participating at the 33rd annual Virtual ROTH Conference taking place March 15–17, 2021. WTER’s participation will include CEO Ricky Wright attending one-on-one meetings with any interested conference attendees. WTER is well recognized for its flagship product — Alkaline88, which is a leading alkaline water brand. Alkaline88 is available in bulk and single-serve sizes as well as eco-friendly aluminum packaging options. The conference is hosted by Roth Capital Partners LLC, a…

MondayMar 15, 2021 3:28 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Reaches Key Milestone Considered Essential Success Factor

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canadian junior exploration company, looks poised to achieve success given its recent appointment of Chris Ford to the company’s advisory board. “Ford will be a significant contributor to the company’s Chilean operations,” reads an article discussing the appointment and GOH’s prospects. “The latest move is in line with GOH’s strategic ambition to attract robust talent pool as the company believes that essential to its success is the right people along with the right product and right timing enhanced by strong commitment. The latest addition to its supervisory board shows that GOH is poised…

MondayMar 15, 2021 3:21 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Expands Sequire Platform to Add New Shelf Registration Feature

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has announced the release of its shelf registration feature. This new addition to SRAX’s software-as-a-service (“SaaS”) platform, Sequire, combines data and technology to provide actionable insights to public companies in regards to their shelf availability. The new shelf registration functionality joins many other unique and robust Sequire features such as warrant management, situation room and shareholder surveys. “This feature is one of many that is defining us as the premier operating system for public companies. Through providing issuers the tools they need to manage…

MondayMar 15, 2021 1:28 pm

QualityStocksNewsBreaks – Mohawk Group Holdings Inc. (NASDAQ: MWK) Expands E-Commerce Portfolio with Launch into Essential Oils Category

Mohawk Group (NASDAQ: MWK) enters a new product category with its latest acquisition of Healing Solutions LLC, a leading online seller of essential oils. Mohawk, a rapidly growing technology-enabled consumer products company, is on a “quest to become the leading e-commerce consumer brands platform,” reads an article on the developments. “MWK paid approximately $15.3 million in cash in addition to issuing approximately 1.4 million shares of Mohawk’s common stock… Healing Solutions is the latest in a string of acquisitions, which Yaniv Sarig — Mohawk Group Holdings Inc.’s co-founder and chief executive officer — hails as a step forward in the…

MondayMar 15, 2021 12:43 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in First-Ever Emerging Growth Virtual Conference

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco will be presenting at the inaugural Emerging Growth Virtual Conference. Scheduled for March 17–18, the virtual conference is presented by M Vest LLC and Maxim Group LLC. The conference agenda includes roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A’s, and presentations from hundreds of issuers both domestically and internationally. CNS Pharmaceuticals is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, and Climaco’s presentation will include an overview of the company. In addition…

Site Search

Company Search

Category: QualityStocksNewsBreaks